Michael K Hise

Title: Innovations in Bladder Disease Treatment by Michael K Hise

Introduction

Michael K Hise is an accomplished inventor based in Columbia, MD (US). He has made significant contributions to the field of bladder disease research, particularly in the diagnosis and treatment of interstitial cystitis (IC). With a total of 4 patents, his work has the potential to improve the lives of many patients suffering from this chronic condition.

Latest Patents

One of Hise's notable patents is focused on the diagnosis of interstitial cystitis. This chronic bladder disease has an unknown etiology and lacks reliably effective treatments. Hise discovered that normal adult human bladder epithelial cells are inhibited from proliferating by an anti-proliferative factor (APF) found in IC urine specimens. This inhibited proliferation may lead to epithelial abnormalities, such as ulcerations and tears in the bladder epithelium. His research also revealed that levels of heparin binding-epidermal growth factor-like growth factor (HB-EGF) are abnormally low in the urine of IC patients compared to asymptomatic controls. This invention proposes using urine levels of HB-EGF as a diagnostic marker for IC.

Another significant patent by Hise involves a method of treating interstitial cystitis with recombinant HB-EGF. He found that the APF in IC urine inhibits HB-EGF production by bladder epithelial cells. The administration of rHB-EGF can block the effects of APF on bladder epithelial cells, thereby reducing chronic damage to the bladder epithelium. This therapy may be beneficial for patients suffering from IC or other diseases characterized by inhibited epithelial cell proliferation.

Career Highlights

Michael K Hise is affiliated with the University System of Maryland, where he continues to advance research in bladder diseases. His innovative approaches and discoveries have positioned him as a key figure in this area of medical research.

Collaborations

Hise has collaborated with notable colleagues, including Susan K Keay and John W Warren, to further enhance the understanding and treatment of interstitial cystitis.

Conclusion

Michael K Hise's contributions to the field of bladder disease research are invaluable. His innovative patents and collaborative efforts have the potential to transform the diagnosis and treatment of interstitial cystitis, offering hope to many patients.